CIK 0002139097 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-16 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-10-16 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-10-15 | 4 | FORM 4 | 2026-10-13 |
| 2026-10-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-13 | 4 | 4 | 2026-10-13 |
| 2026-10-13 | 8-K | 8-K items 5.03,9.01 | 2026-10-13 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-08 |
| 2026-10-09 | S-8 | S-8 | |
| 2026-10-09 | 424B4 | 424B4 | |
| 2026-10-08 | EFFECT | EFFECT items ,, | |
| 2026-10-08 | 3 | FORM 3 | 2026-10-08 |
| 2026-10-08 | 4 | 4 | 2026-10-08 |
| 2026-10-08 | 4 | 4 | 2026-10-08 |
| 2026-10-08 | 4 | 4 | 2026-10-08 |
| 2026-10-08 | 4 | 4 | 2026-10-08 |
| 2026-10-08 | 4 | 4 | 2026-10-08 |
| 2026-10-08 | 4 | 4 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
| 2026-10-08 | 3 | 3 | 2026-10-08 |
Forms on file (last 1,000): 3 14, 4 9, SCHEDULE 13G 2, SCHEDULE 13D 2, DRS/A 2, 8-K 1, S-8 1, 424B4 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TRXB (0.002 USD), /gw/filings/filings?ticker=TRXB&form=8-K, /gw/filings/facts?ticker=TRXB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange